The POEM shows promise for rapidly identifying patients’ opioid-related knowledge gaps and expectations. Correcting misunderstandings and gaps could result in safer use of opioids in a clinical care setting.
This Special Report discusses the management of OIC in patients with advanced illness, including RELISTOR (methylnaltrexone bromide), a second-line therapeutic option that inhibits opioids from binding to target receptors within the GI tract and does not cross the blood-brain barrier.
Oxycodone is frequently initiated for non-cancer pain without first trialing other analgesics. This highlights the need for prescribing practices to be reviewed in light of increasing concerns about adverse drugs events and death due to oxycodone, particularly in older people.
Reassurance, agreeing to avoid opioids, and information gathering were the three most common communication strategies used by physicians and their patients with chronic pain. Those are the findings from a small pilot study conducted to determine how doctors and patients approach the inherent uncertainty of opioid use, given the absence of long-term data about opioids’ efficacy in noncancer or end-of-life pain treatment.
Pain Medicine News continues its three-part Q&A series with Lynn R. Webster, MD, the president of the American Academy of Pain Medicine (AAPM). Part 2 addresses the second goal of his presidency: improving the health care delivery system so that comprehensive treatment is available to patients with chronic pain.
From current evidence, although all BTCP medications provided pain relief within the time frames assessed, transmucosal fentanyl medications achieved a greater level of pain relief in a shorter time frame than placebo or oral morphine.
We conclude that given the clinical ramifications, opioid-induced hyperalgesia is one of the most understudied important aspects of opioid research.
This study identified that women tend to be less adherent to their prescribed opioid analgesic regimen than men. Findings of this study suggest that to improve pain control, efforts to promote patients’ opioid regimen adherence should be given high priority. Clinicians should be particularly aware that there may be some gender difference in adherence to prescribed opioid analgesics. There is a need for better programmatic efforts to improve analgesic adherence.